GlassScriptPhysician profile
Luis A Rentas Leon
NPI 1538627138
$33,866.18
in general payments reported to CMS, 2019-2025
8 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3.70 · 2021: $241 · 2022: $214 · 2023: $342 · 2024: $33K · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,500.00 |
| Food and Beverage | $906.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pbg Puerto Rico LLC | $32,562.61 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $646.01 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $317.97 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $203.63 | 2022-2024 | Xarelto, Invokana |
| Abbott Laboratories | $49.19 | 2023-2024 | Jot Dx |
| Amgen INC. | $31.63 | 2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.32 | 2022 | |
| Medicure Pharma INC. | $24.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Rentas Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.